B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520) | Finanzwire

Basculer en Français

10032	Companies
204141	Keywords
134518	Articles
108298	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

BRIEF

published on 03/11/2026 at 17:10, 3 days 16 hours ago

BRAIN Biotech AG 2026 AGM Results

Annual General Meeting Supervisory Board BRAINBiocatalysts Two-pillar Strategy Enzyme Production
PRESS RELEASE

published on 03/11/2026 at 17:05, 3 days 16 hours ago

Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG
Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG. Shareholders approve all agenda items. New member elected to the Supervisory Board. CEO highlights company's strategy and unique selling points

Annual General Meeting Financial Year Supervisory Board BRAIN Biotech AG Product Innovations
BRIEF

published on 02/25/2026 at 07:35, 18 days 1 hour ago

BRAIN Biotech Reports Q1 Results and SolasCure's Clinical Milestone

Financial Performance BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
PRESS RELEASE

published on 02/25/2026 at 07:30, 18 days 2 hours ago

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
BRAIN Biotech's Q1 25/26 results show revenue decline but improved EBITDA. Breakthrough Aurase Wound Gel by SolasCure for chronic wounds. BRAIN BioIncubator segment thrives

EBITDA BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
BRIEF

published on 01/14/2026 at 07:35, 2 months 1 day ago

BRAIN Biotech AG Shows Resilience Amid Economic Challenges in FY 2024/25

Revenue Decline BRAIN Biotech AG Cost Control Financial Year 2024/25 BRAINBioIncubator
PRESS RELEASE

published on 01/14/2026 at 07:30, 2 months 1 day ago

FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control
BRAIN Biotech AG reports FY 2024/25 financial results showing successful project monetization and cost control measures. Decline in revenues offset by strong cash position

Financial Results Revenue Decline BRAIN Biotech AG Cost Control Project Monetization
BRIEF

published on 09/03/2025 at 09:35, 6 months 11 days ago

BRAIN Biotech AG Names Johan Jansén-Storbacka as EVP

Biotechnology BRAIN Biotech AG Executive Appointment Johan Jansén-Storbacka Enzyme Products
PRESS RELEASE

published on 09/03/2025 at 09:30, 6 months 12 days ago

BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business
BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business on September 1, 2025, succeeding Rod Sears-Black. Johan brings 20+ years of biotechnology experience

BRAIN Biotech Executive Vice President Johan Jansén-Storbacka Enzyme Products Biocatalysts
BRIEF

published on 08/28/2025 at 07:35, 6 months 18 days ago

BRAIN Biotech Reports Solid Q3 Revenue Growth in BRAINBiocatalysts Segment

Financial Results BRAIN Biotech AG Enzyme Business BRAINBiocatalysts Q3 Revenue Growth
PRESS RELEASE

published on 08/28/2025 at 07:30, 6 months 18 days ago

BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts
BRAIN Biotech AG reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts. Despite economic challenges, the company shows positive EBITDA results

Financial Results EBITDA Revenue Growth BRAIN Biotech AG BRAINBiocatalysts

1 2 ... 8

Accesswire

Published on 03/13/2026 at 23:00, 1 day 10 hours ago

CORRECTION FROM SOURCE: EV Nickel Announces Maiden Mineral Resource Estimate for Gemini North Nickel Zone
Published on 03/13/2026 at 23:00, 1 day 10 hours ago

Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor
Published on 03/13/2026 at 21:30, 1 day 12 hours ago

Alset AI Announces Closing of Shares for Debt Transaction
Published on 03/13/2026 at 17:20, 1 day 16 hours ago

Tocvan Partners With VRIFY to Accelerate Exploration and Enhance Discovery Potential With AI at Gran Pilar
Published on 03/13/2026 at 14:00, 1 day 19 hours ago

CCL Industries Signs Agreement to Acquire Sleever International

View all ACCESSWIRE

EQS Group

Published on 03/15/2026 at 00:35, 8 hours 56 minutes ago

Lord Ashcroft's VCs and GCs to have a new home at the National Army Museum
Published on 03/14/2026 at 23:20, 10 hours 11 minutes ago

WIRobotics Selected for the Physical AI Fellowship Powered by AWS, NVIDIA, and MassRobotics
Published on 03/14/2026 at 15:55, 17 hours 36 minutes ago

ISLE 2026 Successfully Defining New Trends in Smart Display and System Integration
Published on 03/14/2026 at 15:20, 18 hours 11 minutes ago

China International Supply Chain Expo Unveils AI Zone as 100-Day Countdown Begins With 500+ Exhibitors
Published on 03/14/2026 at 10:25, 23 hours 6 minutes ago

Rendeavour and Wellington College Education to open global British School in Tatu City, Kenya

Les Echos

Published on 03/13/2026 at 19:50, 1 day 13 hours ago

Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 1 day 15 hours ago

Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 2 days 2 hours ago

BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 2 days 15 hours ago

NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
Published on 03/12/2026 at 15:06, 2 days 18 hours ago

FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025

View all LES ECHOS COMFI WIRE